Intelligence Driven Advisers, LLC Takeda Pharmaceutical CO LTD Call Options Transaction History
Intelligence Driven Advisers, LLC
- $515 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TAK
# of Institutions
345Shares Held
68.4MCall Options Held
1.72MPut Options Held
178K-
Capital Research Global Investors Los Angeles, CA13.2MShares$198 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.6MShares$84.2 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$69.6 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$63.4 Million0.05% of portfolio
-
First Trust Advisors LP Wheaton, IL3.24MShares$48.7 Million0.04% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $46.7B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...